Expression levels of major histocompatibility complex class II molecules, including HLA-DRA, HLA-DRB5, HLA-DPA1, and HLA-DQB1, which are expected to be increased following MAC activation in the COVID-19 group, were found to decrease (Fig. 3G). This evidence concerns the gene HLA-DPA1 and COVID-19.